- Fee assured
- Verified this account
- Movement disorders
- Multiple sclerosis (MS)
I am David Paling, a consultant neurologist with practices at the Royal Hallamshire Hospital in Sheffield, Doncaster Royal Infirmary and Park Hill Hospital.
I am the clinical lead for the internationally renowned MS Centre Sheffield which has been recently featured in BBC Panorama. I am also an honorary senior lecturer at the University of Sheffield, Honorary Strategic Director for the Multiple Sclerosis Academy and the chair of the infrastructure working group of the MS Society.
As well as interests in multiple sclerosis I also specialise in headache and I run a teaching course for local general practitioners on diagnosis and treatments. I am also interested in epilepsy, seizures, blackouts and Parkinson’s disease and I have published peer reviewed articles and chapters on these topics.
I trained at University College London, The University of Manchester and The University of Sydney.
As part of my practice I see patients with all sorts of neurological symptoms including headaches, seizures, blackouts, weakness, numbness, tingling, nerve pains, visual problems, bladder problems, balance problems, walking problems, incoordination and problems with dexterity.
I see people with complicated symptoms which are hard to put together, and ensure that I take the time discuss all of your concerns and symptoms.
I understand that having neurological symptoms and seeing a specialist can be very daunting. I work very hard in my practice to to ensure that I do all I can to put people at their ease, take time to understand their symptoms and their impact, and work together on a investigation and management plan. I regularly survey patients who attend my practise using the RES360 system. The most up to date results are in the outcomes section.
In view of my specialist knowledge I look after patients in a very large geograpical area encompassing Doncaster, Sheffield, Leeds, York, Goole, Beverly, Hull, Barnsley, Rotherham, Hathersage, Baslow, Bakewell, Chesterfield, Pontefract, Wakefield, Retford, Worksop, Lincoln, Scunthorpe, Belton, Epworth, Gainsborough and Mansfield.
Areas of interest
Multiple Sclerosis; Headaches; Epilepsy; Parkinson's disease; Movement Disorders; Stroke; Transient Ischaemic Attack; Medically Unexplained Symptoms; Driving Queries
- MS Academy: https://multiplesclerosisacademy.org/
- MS Academy Speaker Profile: https://multiplesclerosisacademy.org/speakers/dr-david-paling/
Current NHS consultant posts held
Consultant Neurologist, Royal Hallamshire Hospital Sheffield
Consultant Neurologist, Doncaster Royal Infirmary
Use of technology in healthcare
Clinical trial infrastructure
Improving access of patients to clinical trials
I really enjoy teaching medical students, doctors in training, general practitioners and other neurologists.
I regularly give teaching sessions and I am the honorary strategic director of the MS Academy which aims to improve the care of all patients with MS in the UK by better education of health care practioners.
Outside of work I enjoy running and looking after my young family of 2 girls and a boy.
2018 Best supervisor award, MSc Neurology Programme, University of Sheffield
2017 Center for Assistive Technology Innovation Award
2014 Presentation award, Neuro SpR MS teaching weekend
2013 Liversidge Prize, North of England Neurological Association
2012 Best poster in ECTRIMS 2012
2012 Guarantors of Brain scholarship
2011 ECTRIMS foundation scholarship
2009 Sidney Driscoll Neuroscience Foundation Award
2009 Quality Improvement Award, Lancashire Teaching Hospitals
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119433/
Brain connectivity and cognitive processing speed in multiple sclerosis: A systematic review. J Neurol Sci. 2018 May 15;388:115-127
Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937879/
Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.
Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602172/
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurology. 2016; 15:259-69
Axonal conduction in multiple sclerosis: A combined magnetic resonance imaging and electrophysiological study of the medial longitudinal fasciculus. Mult Scler. 2015 Jun;21(7):905-15
Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887342/
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis. Brain 2013; 136:2305-17
Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content. J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):785-92
Carotid sinus syndrome is common in very elderly patients undergoing tilt table testing and carotid sinus massage because of syncope or unexplained falls. Aging Clin Exp Res. 2011 Aug;23(4):304-8.
Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31]. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189869/
Energy failure in multiple sclerosis and its investigation using MR techniques. J Neurol 2011; 258:2113-27
A treatable cause for a painful movement disorder. Pract Neurol 2010; 10:351-4
Midodrine hydrochloride is safe and effective in older people with neurocardiogenic syncope. J Am Geriatr Soc. 2010 Oct;58(10):2026-7
Courses offered to GPs
I have taken part in TARGET sessions in Doncaster.
I have offered bespoke teaching sessions to local general practises and happy to be approached for any other sessions.
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://sheffieldacuk0-my.sharepoint.com/:b:/g/personal/d_j_paling_sheffield_ac_uk/EekJedPm-41KivwzrQJjMMYBQl4Mif2rKPQh-Sj0kR3bOw?e=k0KbzV
- MB ChB University of Manchester 2003
- BSc first class with Honours in Biomedical Sciences University of Manchester 2000
- Member of the Royal College of Physicians Royal College of Physicians, London 2006
- PhD in Neurology University College London 2014
- Multiple Sclerosis Academy Neurology Academy 2016
Reference number 6078639
Professional bodies (positions held - last 3 yrs)
- Clinical Lead MS Centre Sheffield 2015
- Honorary Senior Lecturer University of Sheffield 2014
- Honorary Strategic Director Multiple Sclerosis Academy 2017
- Chair of the Infrastructure Working Group Multiple Sclerosis Society 2018
Details of entry to specialist register
- Neurology, 2014
Affiliations / memberships
Member of the Association of British Neurologists
Member of the British Association for the Study of Headache
Faculty of the Multiple Sclerosis Academy
Member of the Royal College of Physicians
- Thorne RoadDONCASTERDN2 5TH
- 16:00 - 20:00
- 07450 019945
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details